CUTIA-B
024872.3402.50% ( -0.060 )
CUTIA-B (02487)
Cutia Therapeutics an investment holding company, engages in the research, development, manufacture, and commercialization of scalp diseases and care products,...
- Open
- 2.400
- High
- 2.400
- Low
- 2.340
- Prev. Close
- 2.400
- Volume
- 45.20K
- Turnover
- 107.67K
- Avg Price
- 2.382
- Bid/Ask Ratio
- -66.67%
- Amplitude
- 2.50%
- 52wk High
- 12.000
- Volume Ratio
- 0.44
- Turnover Ratio
- 0.01%
CUTIA-B Analyst Rating
View MoreForecast & Rating
May 8, 2026Price forecast
HK$11.29382.37%
Forecast & RatingBuy
2analysts
- Strong buy50.00%
- Buy50.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 22 at 04:18 AM
Hong Kong Equities Flash Mixed Signals as Airlines Brace for Losses, Biotech Advances
- PUBT · Jul 2 at 08:06 AM
Cutia Therapeutics next-day disclosure return reports 9,803,014 new shares issued on HKEX
- PUBT · Jun 26 at 03:31 AM
Cutia Therapeutics AGM resolutions passed in shareholder vote
- Tip Ranks · May 6 at 06:55 PM
Cutia Wins NMPA Nod for Topical Anesthesia Cream, Expanding China Dermatology Portfolio
- AASTOCKS · Mar 24 at 03:32 AM
"Performance" CUTIA's annual loss narrowed to 340 million RMB, no dividend declared
- Zhitong · Nov 3, 2025 at 07:42 AM
CUTIA-B plans to issue 14.998 million shares according to the share scheme
